SCANDMEDICAL SOLDK (Germany) Performance

K41 Stock   0.59  0.01  1.67%   
On a scale of 0 to 100, SCANDMEDICAL SOLDK holds a performance score of 6. The firm owns a Beta (Systematic Risk) of 0.22, which indicates not very significant fluctuations relative to the market. As returns on the market increase, SCANDMEDICAL SOLDK's returns are expected to increase less than the market. However, during the bear market, the loss of holding SCANDMEDICAL SOLDK is expected to be smaller as well. Please check SCANDMEDICAL SOLDK's downside deviation, standard deviation, and the relationship between the semi deviation and coefficient of variation , to make a quick decision on whether SCANDMEDICAL SOLDK's current price history will revert.

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in SCANDMEDICAL SOLDK 040 are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, SCANDMEDICAL SOLDK reported solid returns over the last few months and may actually be approaching a breakup point. ...more
  

SCANDMEDICAL SOLDK Relative Risk vs. Return Landscape

If you would invest  52.00  in SCANDMEDICAL SOLDK 040 on April 26, 2025 and sell it today you would earn a total of  7.00  from holding SCANDMEDICAL SOLDK 040 or generate 13.46% return on investment over 90 days. SCANDMEDICAL SOLDK 040 is currently producing 0.2348% returns and takes up 2.7538% volatility of returns over 90 trading days. Put another way, 24% of traded stocks are less volatile than SCANDMEDICAL, and 96% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon SCANDMEDICAL SOLDK is expected to generate 3.52 times more return on investment than the market. However, the company is 3.52 times more volatile than its market benchmark. It trades about 0.09 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.23 per unit of risk.

SCANDMEDICAL SOLDK Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for SCANDMEDICAL SOLDK's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as SCANDMEDICAL SOLDK 040, and traders can use it to determine the average amount a SCANDMEDICAL SOLDK's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0853

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsK41
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 2.75
  actual daily
24
76% of assets are more volatile

Expected Return

 0.23
  actual daily
4
96% of assets have higher returns

Risk-Adjusted Return

 0.09
  actual daily
6
94% of assets perform better
Based on monthly moving average SCANDMEDICAL SOLDK is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SCANDMEDICAL SOLDK by adding it to a well-diversified portfolio.

About SCANDMEDICAL SOLDK Performance

By analyzing SCANDMEDICAL SOLDK's fundamental ratios, stakeholders can gain valuable insights into SCANDMEDICAL SOLDK's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if SCANDMEDICAL SOLDK has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if SCANDMEDICAL SOLDK has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.

Things to note about SCANDMEDICAL SOLDK 040 performance evaluation

Checking the ongoing alerts about SCANDMEDICAL SOLDK for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for SCANDMEDICAL SOLDK 040 help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
SCANDMEDICAL SOLDK has some characteristics of a very speculative penny stock
Evaluating SCANDMEDICAL SOLDK's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate SCANDMEDICAL SOLDK's stock performance include:
  • Analyzing SCANDMEDICAL SOLDK's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether SCANDMEDICAL SOLDK's stock is overvalued or undervalued compared to its peers.
  • Examining SCANDMEDICAL SOLDK's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating SCANDMEDICAL SOLDK's management team can have a significant impact on its success or failure. Reviewing the track record and experience of SCANDMEDICAL SOLDK's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of SCANDMEDICAL SOLDK's stock. These opinions can provide insight into SCANDMEDICAL SOLDK's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating SCANDMEDICAL SOLDK's stock performance is not an exact science, and many factors can impact SCANDMEDICAL SOLDK's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for SCANDMEDICAL Stock analysis

When running SCANDMEDICAL SOLDK's price analysis, check to measure SCANDMEDICAL SOLDK's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SCANDMEDICAL SOLDK is operating at the current time. Most of SCANDMEDICAL SOLDK's value examination focuses on studying past and present price action to predict the probability of SCANDMEDICAL SOLDK's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SCANDMEDICAL SOLDK's price. Additionally, you may evaluate how the addition of SCANDMEDICAL SOLDK to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Commodity Directory
Find actively traded commodities issued by global exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format